Bioabsorbable synthetic nonwoven fabric holding thrombin
View Patent ↗A safe and effective hemostatic is provided. The invention relates to a bioabsorbable synthetic nonwoven fabric holding thrombin as an effective ingredient and a hemostatic comprising said bioabsorbable synthetic nonwoven fabric. The bioabsorbable synthetic nonwoven fabric holding thrombin in accordance with the present invention may be prepared by a process which comprises the steps of immersing a bioabsorbable synthetic nonwoven fabric into a solution containing thrombin and of lyophilizing the obtained nonwoven fabric. The bioabsorbable synthetic nonwoven fabric holding thrombin in accordance with the present invention allows for quicker and more effective hemostasis.
1. A bioabsorbable synthetic non-woven fabric holding a hemostatic-effective amount of thrombin,
said non-woven fabric being made of a material comprising polyglycolic acid,
said non-woven fabric having sufficient elasticity and flexibility for sealing tissues of various shapes,
formed by contacting a bioabsorbable synthetic non-woven fabric with a saline solution comprising thrombin optionally containing a pharmaceutically acceptable additive selected from the group consisting of albumin, polyethylene glycol, arginine, hyaluronic acid, glycerol, mannitol and calcium chloride, and lyophilizing the non-woven fabric holding the thrombin,
said bioabsorbable synthetic non-woven fabric being formed by said contacting of the bioabsorbable synthetic nonwoven fabric with the saline solution, wherein said saline solution consists of said thrombin alone or said thrombin containing said pharmaceutically acceptable additive.
2. The bioabsorbable synthetic nonwoven fabric of claim 1 which is free of fibrinogen.
3. The bioabsorbable synthetic nonwoven fabric according to claim 1 , wherein the thrombin is thrombin derived from human blood or a recombinant human thrombin produced by a recombinant DNA technique.
4. The bioabsorbable synthetic nonwoven fabric of claim 1 , formed by freezing prior to said lyophilizing.
5. The bioabsorbable synthetic nonwoven fabric formed by contacting a bioabsorbable synthetic nonwoven fabric with a saline solution of thrombin of claim 1 , wherein the pharmaceutically acceptable additive is present in the saline solution.
6. The bioabsorbable synthetic nonwoven fabric formed by contacting a bioabsorbable synthetic nonwoven fabric with a saline solution of thrombin of claim 4 , wherein the pharmaceutically acceptable additive is present in the saline solution.
7. The bioabsorbable synthetic nonwoven fabric according to claim 1 in sheet form.
8. The bioabsorbable synthetic nonwoven fabric according to claim 6 in sheet form.